Epidemiological Study of Chronic Blood-Borne Viral Hepatitis in a Tertiary Care Facility in Al-Baha, Saudi Arabia: Associations with Liver Enzymes and Treatment Results

1

Chronic hepatitis B and C infections pose significant health risks, with HBV causing 490 cirrhosis cases and 1,740 liver-related deaths in Saudi Arabia.
2

The study analyzed chronic blood-borne viral hepatitis and treatment outcomes at a major hospital in Al-Baha from January 2019 to December 2022.
3

Despite a mass immunization program, HBV prevalence in Saudi Arabia remains at 1.7%, while HCV affects approximately 0.7% of the population.
4

The study utilized retrospective data to assess the regional burden of viral hepatitis and treatment effectiveness in routine clinical practice.
5

Data on treatment adherence and follow-up for sustained virological response were incomplete, highlighting challenges in managing chronic hepatitis.

Bmc Infectious Diseases

by Talal A. Sallam, Rabei M. El-Badry, Turki H. Alkully, Hasan H. Alfahemi, Muhammad A. Halwani, Khaled I. Alzahrani, Manal A. Alghamdi
January 12, 2026

1